Product Code: ETC4858066 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The intravenous (IV) iron drugs market in Sweden is witnessing steady growth due to the rising incidence of iron deficiency anemia, particularly among patients with chronic diseases such as kidney failure and inflammatory bowel disease. The increasing demand for effective and fast-acting treatment options, along with the governments emphasis on improving healthcare access, is driving the market for intravenous iron therapies in Sweden.
The rising prevalence of iron deficiency anemia in Sweden, particularly among patients with chronic diseases such as kidney disorders and cancer, is a major driver for the intravenous iron drugs market. The need for rapid iron replenishment therapies, especially in cases where oral supplements are ineffective, also boosts market growth. Technological advancements in drug formulations further drive this market.
The intravenous iron drugs market in Sweden faces challenges related to patient safety concerns, particularly around side effects such as allergic reactions and infusion site complications. High costs of intravenous treatments compared to oral iron supplements may also deter widespread use. Moreover, there is a lack of awareness among healthcare providers and patients about the benefits of intravenous iron therapies, leading to slower adoption. Strict regulatory requirements for drug approval and market entry can also slow the introduction of new products.
Swedens healthcare system provides comprehensive coverage for essential medications, including intravenous iron drugs. The government regulates drug prices and supports pharmaceutical companies in developing and distributing iron supplements, ensuring affordable treatment options for patients suffering from iron deficiencies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Intravenous Iron Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Intravenous Iron Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Intravenous Iron Drugs Market - Industry Life Cycle |
3.4 Sweden Intravenous Iron Drugs Market - Porter's Five Forces |
3.5 Sweden Intravenous Iron Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Sweden Intravenous Iron Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Sweden Intravenous Iron Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Sweden Intravenous Iron Drugs Market Trends |
6 Sweden Intravenous Iron Drugs Market Segmentations |
6.1 Sweden Intravenous Iron Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Iron Dextran, 2021-2031F |
6.1.3 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Iron Sucrose, 2021-2031F |
6.1.4 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Ferric Carboxymaltose, 2021-2031F |
6.1.5 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Sweden Intravenous Iron Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Chronic Kidney Disease, 2021-2031F |
6.2.3 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F |
6.2.4 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.5 Sweden Intravenous Iron Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Sweden Intravenous Iron Drugs Market Import-Export Trade Statistics |
7.1 Sweden Intravenous Iron Drugs Market Export to Major Countries |
7.2 Sweden Intravenous Iron Drugs Market Imports from Major Countries |
8 Sweden Intravenous Iron Drugs Market Key Performance Indicators |
9 Sweden Intravenous Iron Drugs Market - Opportunity Assessment |
9.1 Sweden Intravenous Iron Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Sweden Intravenous Iron Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Sweden Intravenous Iron Drugs Market - Competitive Landscape |
10.1 Sweden Intravenous Iron Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Intravenous Iron Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |